Jennison Associates LLC 10x Genomics, Inc. Transaction History

Jennison Associates LLC

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 11, 2022	SELL	$55.7 - $145.79 $5.15 Million - $13.5 Million	-92,476 Closed	0 $0
Q4 2021 Feb 08, 2022	SELL	$135.05 - $182.59 $266,588 - $360,432	-1,974 Reduced 2.09%	92,476 $13.8 Million
Q3 2021 Nov 09, 2021	SELL	$145.58 - $192.14 $34.2 Million - $45.2 Million	-235,170 Reduced 71.35%	94,450 $13.8 Million
Q2 2021 Aug 12, 2021	SELL	$134.22 - $202.37 $10.8 Million - $16.3 Million	-80,398 Reduced 19.61%	329,620 $64.5 Million
Q1 2021 May 11, 2021	SELL	$140.25 - $196.86 $4.85 Million - $6.81 Million	-34,591 Reduced 7.78%	410,018 $74.2 Million
Q4 2020 Feb 05, 2021	BUY	$126.47 - $163.7 $11.8 Million - $15.3 Million	93,554 Added 26.65%	444,609 $63 Million
Q3 2020 Nov 04, 2020	BUY	$87.44 - $125.0 $2.06 Million - $2.94 Million	23,543 Added 7.19%	351,055 $43.8 Million
Q2 2020 Aug 06, 2020	BUY	$58.39 - $89.31 $19.1 Million - $29.3 Million	327,512 New	327,512 $29.3 Million

291

94.7M

263K

85.1K

Ticker TXG
Exchange NASDAQ
Sector Healthcare
Industry Health Information Services
Shares Outstandng 95,046,400
Market Cap $1.5B
Description
10x Genomics, Inc., a life science technology company, develops and sells instruments, consumables, and software for analyzing biological systems in North America, Europe, the Middle East, Africa, China, and the Asia Pacific. The company provides chromium and chromium connect instruments, microfluidic chips, slides, reagents, and other consumabl...

Get notified when there are updates to the investment portfolio of Jennison Associates LLC, based on Form 13F filings with the SEC.

Stay updated on Jennison Associates LLC with notifications on news.